Table 3. Vaccinations administered monthly by country before the COVID-19 pandemic, January 2016–February 2020.
| Vaccine (dose) | Vaccinations administered a month, median no. (IQR) |
|||
|---|---|---|---|---|
| Haiti | Lesotho | Liberia | Malawi | |
| Bacillus Calmette–Guerin (1) | 947.0 (797.0 to 1 114.5) | 79.5 (66.2 to 93.8) | 193.0 (158.2 to 233.8) | 488.5 (422.8 to 549.8) |
| Oral or inactivated polio (0) | 338.5 (245.8 to 411.0) | 63.5 (51.5 to 71.0) | 156.5 (125.0 to 186.5) | NA |
| Oral or inactivated polio (1) | 766.5 (609.5 to 1 045.0) | 95.0 (84.2 to 106.8) | 218.0 (175.5 to 247.8) | 501.5 (434.5 to 743.0) |
| Oral or inactivated polio (2) | 707.5 (453.5 to 900.5) | NA | 203.0 (160.8 to 229.0) | 435.5 (361.8 to 467.8) |
| Oral or inactivated polio (3) | 491.5 (352.2 to 590.5) | 89.5 (76.0 to 95.8) | 208.5 (174.5 to 243.0) | 463.5 (394.2 to 501.2) |
| Pentavalent (1) | 791.5 (654.2 to 1 071.0) | 100.0 (79.0 to 106.0) | 218.0 (175.5 to 247.8) | 474.0 (388.2 to 514.0) |
| Pentavalent (2) | 700.0 (538.8 to 909.2) | NA | 203.0 (160.8 to 230.5) | 438.0 (367.2 to 463.8) |
| Pentavalent (3) | 612.0 (532.8 to 835.8) | 86.5 (74.5 to 95.8) | 208.5 (175.2 to 243.0) | 462.5 (397.2 to 506.0) |
| Pneumococcal conjugate (1) | 635.7 (381.1 to 857.0) | NA | 218.0 (175.5 to 246.2) | 466.5 (401.2 to 519.0) |
| Pneumococcal conjugate (2) | 443.3 (208.0 to 668.8) | NA | 203.0 (160.8 to 229.0) | 440.5 (366.5 to 463.0) |
| Pneumococcal conjugate (3) | 289.7 (143.1 to 464.5) | NA | 208.5 (174.5 to 243.0) | 459.5 (393.5 to 507.0) |
| Rotavirus (1) | 743.5 (592.2 to 986.5) | NA | 216.5 (159.2 to 242.2) | 470.5 (368.2 to 503.2) |
| Rotavirus (2) | 675.0 (484.0 to 843.5) | NA | 197.5 (129.2 to 223.5) | 431.5 (354.0 to 471.8) |
| Measles (1) | 564.0 (489.0 to 690.0) | 78.0 (62.2 to 92.8) | 181.5 (139.0 to 222.2) | 259.5 (0.0 to 486.8) |
Covid-19: coronavirus disease 2019; IQR: interquartile range; NA: data not available.